Human CD147/EMMPRIN PharmaGenie ELISA Kit (SBRS0362)

CD147, also designated EMMPRIN (Extracellular Matrix Metalloproteinase Inducer) or Basigin, is a highly glycosylated transmembrane immunoglobulin-like receptor implicated in tumor invasion, angiogenesis, and inflammatory signaling. This PharmaGenie kit from Assay Genie quantifies soluble CD147 in cell culture supernatants and clinical specimens using a quantitative immunoassay format, providing researchers with a reproducible tool for investigating biomarker expression in oncology, immunology, and infectious disease studies, including malaria research where the molecule serves as a receptor for Plasmodium falciparum invasion of human erythrocytes.

The kit contains a pre-coated microplate, biotinylated detection antibody, streptavidin-HRP conjugate, recombinant standards, and assay buffers sufficient for 96 determinations, with a recommended sample volume of 100 µL per well. Reconstituted reagents should be stored refrigerated and protected from light to maintain activity. Intended for research use only, the assay supports studies of extracellular matrix remodeling, monocarboxylate transporter regulation, and tumor-stroma interactions across in vitro cell culture models and ex vivo sample analysis.